Stay updated with breaking news from Multiple Ascending Dose Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
TORONTO, ON / ACCESSWIRE / March 27, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and
Structure Therapeutics announced that the Company will present three scientific posters at the upcoming 2023 American Thoracic Society (ATS) International Conference.
- On Track to Report Initial Data from ACHIEVE Clinical Trial of DYNE-101 in DM1 and DELIVER Clinical Trial of DYNE-251 in DMD During the Second Half of 2023 - WALTHAM, Mass., May 11, 2023 -- Dyne... | May 11, 2023
/PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced new Phase 1 data from AMG 133, a novel bispecific glucose-dependent insulinotropic polypeptide receptor...
STOCKHOLM, SWEDEN / ACCESSWIRE / August 2, 2022 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6)AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of small molecule